Evidence map›Paper›PMID 19287484›Full record

ArticlePloS one2009

Clique-finding for heterogeneity and multidimensionality in biomarker epidemiology research: the CHAMBER algorithm.

Richard A Mushlin, Stephen Gallagher, Aaron Kershenbaum, Timothy R Rebbeck

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Transactional database transformation and its application in prioritizing human disease genes.IEEE/ACM transactions on computational biology and bioinformatics
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Richard A MushlinPsychoGenics Inc, Tarrytown, NY, USA.
Stephen Gallagher
Aaron Kershenbaum
Timothy R Rebbeck
University of Pennsylvania · USIBM Research - Thomas J. Watson Research Center · USPsychogenics (United States) · US

Funding

MOLECULAR SUSCEPTIBILITY TO HORMONE INDUCED CANCERP01CA077596 · NCI · UNIVERSITY OF PENNSYLVANIA · PI STROM, BRIAN LESLIE · 1998 to 2002
$5.6M
NCI NIH HHS P01 CA077596NCI NIH HHS P01-CA77596
6 · The paper itself

Abstract

backgroundCommonly-occurring disease etiology may involve complex combinations of genes and exposures resulting in etiologic heterogeneity. We present a computational algorithm that employs clique-finding for heterogeneity and multidimensionality in biomedical and epidemiological research (the "CHAMBER" algorithm). METHODOLOGY/PRINCIPAL

findingsThis algorithm uses graph-building to (1) identify genetic variants that influence disease risk and (2) predict individuals at risk for disease based on inherited genotype. We use a set-covering algorithm to identify optimal cliques and a Boolean function that identifies etiologically heterogeneous groups of individuals. We evaluated this approach using simulated case-control genotype-disease associations involving two- and four-gene patterns. The CHAMBER algorithm correctly identified these simulated etiologies. We also used two population-based case-control studies of breast and endometrial cancer in African American and Caucasian women considering data on genotypes involved in steroid hormone metabolism. We identified novel patterns in both cancer sites that involved genes that sulfate or glucuronidate estrogens or catecholestrogens. These associations were consistent with the hypothesized biological functions of these genes. We also identified cliques representing the joint effect of multiple candidate genes in all groups, suggesting the existence of biologically plausible combinations of hormone metabolism genes in both breast and endometrial cancer in both races.

conclusionsThe CHAMBER algorithm may have utility in exploring the multifactorial etiology and etiologic heterogeneity in complex disease.

Indexed as

AlgorithmsBiomarkersEpidemiologic StudiesBreast NeoplasmsCase-Control StudiesFemaleGenetics, PopulationHumansOvarian NeoplasmsBiomarkers

Identifiers

PMID19287484
PMCPMC2653643
OpenAlexW1979393673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.